Concerning Hrasls3, a member of the HREV107 type II tumor suppressors, it has been shown to exert anti-proliferative and pro-apoptotic actions and to be down-regulated by Ras-dependent signaling [40-42]. Here, PLAAT3 is linked to neoplasm.